Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael A. Turik
Michael A. Turik
Eli Lilly and Company
Medicine
Internal medicine
Anesthesia
QT interval
Signal averaging
5
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety of the antimyostatin monoclonal antibody LY2495655 in healthy subjects and patients with advanced cancer.
2012
Journal of Clinical Oncology
Gayle S. Jameson
Daniel D. Von Hoff
Glen J. Weiss
Donald A. Richards
David Smith
Carlos Becerra
Mitchell C. Benson
Zheng Yuan
Deborah A. Robins
Michael A. Turik
Margaret M. Wagner
Leijun Hu
Boris Lin
Show All
Source
Cite
Save
Citations (14)
Assess the Effects of Tadalafil on the Human QT Interval Electrocardiographic Sampling and Signal Averaging as a Sensitive Method to The Combined Use of Ibutilide as an Active Control With Intensive
2010
Robert A. Kloner
Arash Bakhtyari
Margaret R. Warner
Jeremy N. Ruskin
Louis R. Cantilena
Wei Shen
Timothy M. Costigan
Alun Bedding
Michael A. Turik
Charles M. Beasley
Malcolm I. Mitchell
Alexandra Dmitrienko
Show All
Source
Cite
Save
Citations (0)
The Combined Use of Ibutilide as an Active Control With Intensive Electrocardiographic Sampling and Signal Averaging as a Sensitive Method to Assess the Effects of Tadalafil on the Human QT Interval
2005
Journal of the American College of Cardiology
Charles M. Beasley
Malcolm I. Mitchell
Alex Dmitrienko
Jeffrey T. Emmick
Wei Shen
Timothy M. Costigan
Alun Bedding
Michael A. Turik
Arash Bakhtyari
Margaret R. Warner
Jeremy N. Ruskin
Louis R. Cantilena
Robert A. Kloner
Show All
Source
Cite
Save
Citations (32)
DOUBLE-MASKED, RANDOMIZED, PARALLEL-GROUP COMPARISON OF CEFACLOR AF AND CEFACLOR IN THE TREATMENT OF ACUTE BACTERIAL SINUSITIS
1997
Current Therapeutic Research-clinical and Experimental
Michael A. Turik
Michael A. Watkins
Don Johns
Show All
Source
Cite
Save
Citations (4)
1